Literature DB >> 15771689

Neonatal hyperbilirubinemia and the bilirubin uridine diphosphate-glucuronosyltransferase gene: the common -3263T > G mutation of phenobarbital response enhancer module is not associated with the neonatal hyperbilirubinemia in Japanese.

Masayo Kanai1, Kazuki Kijima, Emi Shirahata, Ayako Sasaki, Kazuhiro Akaba, Kazuo Umetsu, Naohiro Tezuka, Hirohisa Kurachi, Shogo Aikawa, Kiyoshi Hayasaka.   

Abstract

BACKGROUND: Neonatal hyperbilirubinemia is frequent and severe in Japanese newborns. Previously, it has been reported that half of the Japanese neonates with severe hyperbilirubinemia carried the 211G > A (p.G71R) mutation of the bilirubin uridine diphosphate-glucuronosyltransferase (UGT1A1) gene causing Gilbert syndrome. Recently, it was reported that the -3263T > G mutation in the phenobarbital response enhancer module in UGT1A1 was associated with the majority of cases of Gilbert syndrome. The gene frequency of the -3263T > G mutation was determined and the relation with neonatal hyperbilirubinemia in Japanese was studied.
METHODS: UGT1A1 in 119 neonates born at Yamagata University Hospital, Yamagata, Japan, and 26 subjects who had undergone phototherapy due to severe hyperbilirubinemia at four other hospitals were studied. The gene frequency of -3263T > G mutation in Japanese, Korean, Chinese and German healthy adult controls was also determined. Hyperbilirubinemia was assessed with a Jaundice Meter and UGT1A1 was analyzed by sequence determination or restriction enzyme method.
RESULTS: The gene frequency of the -3263T > G mutation was 0.26 in Japanese subjects and was similar to the prevalence in Korean, Chinese and German populations. However, there was no significant increase in the gene frequency of the mutation in the neonates who required phototherapy for hyperbilirubinemia compared to that in the neonates without severe hyperbilirubinemia. In addition, neonates with or without the mutation did not show a significant change in the level of bilirubin and the mutation also did not show a synergic effect with the 211G > A mutation on the level of bilirubin.
CONCLUSION: The -3263T > G mutation is not likely to be associated with the neonatal hyperbilirubinemia in Japanese.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15771689     DOI: 10.1111/j.1442-200x.2005.02030.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  6 in total

1.  Association of neonatal hyperbilirubinemia in breast-fed infants with UGT1A1 or SLCOs polymorphisms.

Authors:  Hiroko Sato; Toshihiko Uchida; Kentaro Toyota; Tomohiro Nakamura; Gen Tamiya; Miyako Kanno; Taeko Hashimoto; Masashi Watanabe; Kuraaki Aoki; Kiyoshi Hayasaka
Journal:  J Hum Genet       Date:  2014-11-13       Impact factor: 3.172

2.  Association between UGT1A1*28*28 genotype and lung cancer in the Japanese population.

Authors:  Yoshitaka Nishikawa; Masashi Kanai; Maiko Narahara; Akiko Tamon; J B Brown; Kei Taneishi; Masahiko Nakatsui; Kazuya Okamoto; Yu Uneno; Daisuke Yamaguchi; Teruko Tomono; Yukiko Mori; Shigemi Matsumoto; Yasushi Okuno; Manabu Muto
Journal:  Int J Clin Oncol       Date:  2016-11-10       Impact factor: 3.402

3.  [A case of Gilbert syndrome caused by UGT1A1 gene compound heterozygous mutations].

Authors:  Weijie Ou; Su Lin; Yilong Wu; Yueyong Zhu
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25

4.  UGT1A1 gene variants and clinical risk factors modulate hyperbilirubinemia risk in newborns.

Authors:  P K Tiwari; A Bhutada; R Agarwal; S Basu; R Raman; A Kumar
Journal:  J Perinatol       Date:  2013-11-14       Impact factor: 2.521

5.  UGT1A1 sequence variants and bilirubin levels in early postnatal life: a quantitative approach.

Authors:  Neil A Hanchard; Jennifer Skierka; Amy Weaver; Brad S Karon; Dietrich Matern; Walter Cook; Dennis J O'Kane
Journal:  BMC Med Genet       Date:  2011-04-22       Impact factor: 2.103

6.  Association of Neonatal Hyperbilirubinemia with UGT1A1 Gene Polymorphisms: A Meta-Analysis.

Authors:  Zibi Yu; Kaichang Zhu; Li Wang; Ying Liu; Jianmei Sun
Journal:  Med Sci Monit       Date:  2015-10-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.